课题基金 / 基金详情

Phylogenetic and experimental reconstruction of zoonotic transmission of human coronaviruses

Phylogenetic and experimental reconstruction of zoonotic transmission of human coronaviruses
人类冠状病毒人畜共患传播的系统发育和实验重建
批准号:
226350623
负责人:
Professor Dr. Christian Drosten
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2016-12-31

项目摘要

项目成果

Professor Dr. Christian Drosten的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Coronaviruses have received considerable attention since the emergence of SARS-CoV in China 2002/2003. SARS-CoV infection in people exemplified that coronaviruses can cross the species barrier from an animal reservoir to humans and cause severe and lethal disease in humans. Theemergence of MERS-CoV in 2012 showed that zoonotic transmission of coronaviruses is not a rare event. Both viruses have close relatives in bats, and moreover, intermediate hosts, such asracoon dogs, civet cats (SARS-CoV) and dromedary camels (MERS-CoV) have been proposed to facilitate zoonotic transmission. The discovery that dromedary camels harbour MERS-CoV and may act as a bridge reservoir between bats and humans provides an important paradigm for the ecology of viral emergence. Interestingly, the human coronavirus 229E (HCoV-229E; causing common cold in humans), appears to have a similar history of zoonotic transmission, since close relatives were detected in bats as well as in camelid species (alpacas and dromedary camels). While MERS-CoV has a very recent history of zoonotic transmission and differences between viruses isolated from humans and camels are rather small, camel-229E-like-CoV and HCoV-229E have already diverged considerably.The aim of the proposed project is to identify and characterize critical species barriers of CoV zoonotic transmission by using the HCoV-229E system as a model. We will analyse species barriers at the virus entry step (spike-receptor interaction) and during intracellular replication. Importantly, our studies involve bat- camel- and human 229E viruses and primary airway epithelial cultures of their authentic hosts, allowing us to mimic cross-species infection of the upper airways. Specifically, we will focus on:(a) host determinants of cross species transmission, namely innate immune responses (type I interferon system), and we will assess if non-coding RNAs (long non-coding RNA and micro-RNAs) may constitute a critical species barrier, and(b) virus determinants of cross species transmission by following virus adaptation to a new host, and identification of genomic regions/viral domains that are most volatile during adaptation. Relevance: Bats have been shown to harbour a wide variety of diverse CoV species, including close relatives of human coronaviruses (HCoV-229E, SARS-CoV, MERS-CoV). Therefore it is important to define critical virus-host interactions that impact on cross-species transmission. The availability of several full-length bat-229E-like-CoV genome sequences, the discovery of a camel-229E-like-CoV, and the availability of primary epithelial target cells from the authentic hosts offers an unprecedented opportunity to study critical species barriers for the zoonotic transmission of CoVs. This information is extremely valuable to assess the risk of possible future zoonotic transmissions and provide a conceptional framework for efficacious antiviral intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Coronaviruses as a paradigm for the transmission interface between wildlife, livestock and humans
Ecology and species barriers in emerging viral diseases - Proposal for the coordination of DFG priority program (SPP) 1596 -
  • 批准号:
    232958665
  • 项目类别:
    Priority Programmes
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Professor Dr. Christian Drosten
  • 依托单位:
Processes and mechanisms driving virus prevalence, evolutionary potential and emergence from wildlife reservoirs: integrating host and viral traits in a multi-taxa approach across landscapes
Virus biology, host ecology, and human behaviour as determinants for coronaviral zoonoses
国内基金
海外基金
TXNIP调控实验性青光眼视乳头星形胶质细胞的激活及其机制研究
  • 批准号:
    82371048
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    钟一声
  • 依托单位:
GLS1通过α-KG调控表观遗传修饰在实验性近视巩膜重塑中的作用机制
  • 批准号:
    82371092
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    柯碧莲
  • 依托单位:
多发性硬化相关microRNA和靶基因鉴定及其对Th17和Treg细胞生成及分化的作用
  • 批准号:
    81171120
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2011
  • 负责人:
    付锦
  • 依托单位: